Topic: Sally Sussman

The Obama administration's mandate for insurance coverage of contraceptives is framed as a windfall for the pharmaceutical industry. By eliminating co-pays, the policy encourages the use of expensive brand-name drugs over generics, benefiting companies like Pfizer. This shift is expected to drive up overall insurance premiums despite the lack of immediate cost to the consumer.